Flammer Martina M.D.'s Form 4 filing
INSMED IncINSM · filed Feb 4, 2026
- Accession no.
- 0001796960-26-000008
- Filed
- Feb 4, 2026
- Trade date
- Feb 2-3, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.36M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Flammer Martina M.D.CIK 0001796960 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | MOption exerciseAcquired | +7,982 | $65.72 | +$524,577.04 | 92,889 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −563 | $152.06F2 | −$85,609.78 | 92,326 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −928 | $153.16F3 | −$142,132.48 | 91,398 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −3,349 | $154.56F4 | −$517,621.44 | 88,049 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −3,042 | $155.46F5 | −$472,909.32 | 85,007 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −100 | $156.86 | −$15,686 | 84,907 | Direct | |
| Feb 3, 2026 | Common Stock | SSaleDisposed | −795 | $155.77 | −$123,837.15 | 84,112 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Common Stock | MOption exerciseDisposed | −7,982 | $0.00 | $0 | 23,948 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 563 shares sold at prices ranging from $151.76 to $152.74 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F3
This is the weighted average sales price representing 928 shares sold at prices ranging from $152.77 to $153.31 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average sales price representing 3,349 shares sold at prices ranging from $154.10 to $155.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F5
This is the weighted average sales price representing 3,042 shares sold at prices ranging from $155.10 to $155.96 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.